381 related articles for article (PubMed ID: 30825650)
1. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
Whyte MP; McAlister WH; Mumm S; Bierhals AJ
Bone; 2019 May; 122():231-236. PubMed ID: 30825650
[TBL] [Abstract][Full Text] [Related]
2. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
Whyte MP
J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
[TBL] [Abstract][Full Text] [Related]
3. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.
Whyte MP; Zhang F; Wenkert D; Mumm S; Berndt TJ; Kumar R
Bone; 2020 May; 134():115300. PubMed ID: 32112990
[TBL] [Abstract][Full Text] [Related]
4. Asfotase alfa therapy for children with hypophosphatasia.
Whyte MP; Madson KL; Phillips D; Reeves AL; McAlister WH; Yakimoski A; Mack KE; Hamilton K; Kagan K; Fujita KP; Thompson DD; Moseley S; Odrljin T; Rockman-Greenberg C
JCI Insight; 2016 Jun; 1(9):e85971. PubMed ID: 27699270
[No Abstract] [Full Text] [Related]
5. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
Kishnani PS; Rockman-Greenberg C; Rauch F; Bhatti MT; Moseley S; Denker AE; Watsky E; Whyte MP
Bone; 2019 Apr; 121():149-162. PubMed ID: 30576866
[TBL] [Abstract][Full Text] [Related]
6. Hypophosphatasia: An overview For 2017.
Whyte MP
Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
[TBL] [Abstract][Full Text] [Related]
7. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia.
Rolvien T; Schmidt T; Schmidt FN; von Kroge S; Busse B; Amling M; Barvencik F
Bone; 2019 Oct; 127():67-74. PubMed ID: 31152801
[TBL] [Abstract][Full Text] [Related]
8. Hypophosphatasia: From Diagnosis to Treatment.
Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
[TBL] [Abstract][Full Text] [Related]
9. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.
Bowden SA; Foster BL
Drug Des Devel Ther; 2018; 12():3147-3161. PubMed ID: 30288020
[TBL] [Abstract][Full Text] [Related]
10. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
Scott LJ
Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272
[TBL] [Abstract][Full Text] [Related]
11. Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health.
Lin EL; Gottesman GS; McAlister WH; Bijanki VN; Mack KE; Griffin DM; Mumm S; Whyte MP
Bone; 2020 Jul; 136():115322. PubMed ID: 32200022
[TBL] [Abstract][Full Text] [Related]
12. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
Kishnani PS; Rush ET; Arundel P; Bishop N; Dahir K; Fraser W; Harmatz P; Linglart A; Munns CF; Nunes ME; Saal HM; Seefried L; Ozono K
Mol Genet Metab; 2017 Sep; 122(1-2):4-17. PubMed ID: 28888853
[TBL] [Abstract][Full Text] [Related]
13. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
Whyte MP; Coburn SP; Ryan LM; Ericson KL; Zhang F
Bone; 2018 May; 110():96-106. PubMed ID: 29360619
[TBL] [Abstract][Full Text] [Related]
14. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
[TBL] [Abstract][Full Text] [Related]
15. Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale.
Whyte MP; Fujita KP; Moseley S; Thompson DD; McAlister WH
J Bone Miner Res; 2018 May; 33(5):868-874. PubMed ID: 29297597
[TBL] [Abstract][Full Text] [Related]
16. Hypophosphatasia: presentation and response to asfotase alfa.
Alsarraf F; Ali DS; Almonaei K; Al-Alwani H; Khan AA; Brandi ML
Osteoporos Int; 2024 Apr; 35(4):717-725. PubMed ID: 37993691
[TBL] [Abstract][Full Text] [Related]
17. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters.
Guañabens N; Mumm S; Möller I; González-Roca E; Peris P; Demertzis JL; Whyte MP
J Bone Miner Res; 2014 Apr; 29(4):929-34. PubMed ID: 24123110
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.
Liu J; Campbell C; Nam HK; Caron A; Yadav MC; Millán JL; Hatch NE
Bone; 2015 Sep; 78():203-11. PubMed ID: 25959417
[TBL] [Abstract][Full Text] [Related]
19. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
Bowden SA; Foster BL
Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504
[TBL] [Abstract][Full Text] [Related]
20. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
Stürznickel J; Schmidt FN; von Vopelius E; Delsmann MM; Schmidt C; Jandl NM; Oheim R; Barvencik F
Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
